Kerr/Pentron, DBA Kerr Corporation and Pentron Clinical
FDA classification date
Jul 5, 2019
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II
Reason stated in the source
Immersion time stated on the bottle is 45 minutes while the product instructions say 90 minutes.
Source facts
Action
On July 13, 2018, Metrex Research Corp., a subsidiary of Kerr Corporation, sent URGENT NOTICE: Regimen Glutaraldehyde letters to their consignees instructing them to check their inventory and complete the enclosed Field Action Acknowledement and Product Return Form. Distributors were requested to conduct sub-recalls to their consignees.
Initiated
2018-07-13
Root cause
Error in labeling
Terminated
2021-05-05
Distribution
AZ, CA, CO, FL, GA, IL, KY, LA, MA, MN, MO, NJ, NY, OH, PA, SC, TN, TX, UT, VA, and WA.
Recall number
Z-1721-2019
Recall status
Terminated
CDRH record ID
171828
FDA classified
2019-07-05
Recall event number
82553
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.